Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wu, Ying ^a,b   Lyu, Hui ^b   Liu, Hongbing ^a   Shi, Xuefei ^c   Song, Yong ^a   Liu, Bolin ^b  

^a NANJING UNIVERSITY   (China)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c HUZHOU CENTRAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; GAS5 LONG NON-CODING RNA, HUMAN; HISTONE DEACETYLASE INHIBITOR; LONG UNTRANSLATED RNA; RNA;

AGED; CELL MOTION; DOWN REGULATION; DRUG EFFECTS; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENETIC EPIGENESIS; GENETICS; HISTONE CODE; HUMAN; LUNG TUMOR; MALE; METABOLISM; METASTASIS; MIDDLE AGED; NON SMALL CELL LUNG CANCER; SECONDARY; TUMOR CELL LINE; TUMOR INVASION;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; EPIGENESIS, GENETIC; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HISTONE CODE; HISTONE DEACETYLASE INHIBITORS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RNA, ANTISENSE; RNA, LONG NONCODING; RNA, NEOPLASM;

EID: 84982862091     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep31093     Document Type: Article

References (46)

1. Siegel, R., Ma, J., Zou, Z., Jemal, A. Cancer statistics. CA Cancer J Clin 64, 9-29 (2014).
2. Stewart, D. J. Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer. Crit Rev Oncol Hematol 75, 173-234 (2010).
3. Wu, Y. K. et al. Nuclear survivin expression: a prognostic factor for the response to taxane-platinum chemotherapy in patients with advanced non-small cell lung cancer. Med Oncol 31, 79 (2014).
4. Schiller, J. H. et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346, 92-98 (2002).
5. Ettinger, D. S. et al. Non-small cell lung cancer. J Natl Compr Canc Netw 8, 740-801 (2010).
6. Ponting, C. P., Oliver, P. L., Reik, W. Evolution and functions of long noncoding RNAs. Cell 136, 629-641 (2009).
7. Ulitsky, I., Bartel, D. P. lincRNAs: genomics, evolution, mechanisms. Cell 154, 26-46 (2013).
8. Wang, K. C., Chang, H. Y. Molecular mechanisms of long noncoding RNAs. Mol Cell 43, 904-914 (2011).
9. Derrien, T. et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, expression. Genome Res 22, 1775-1789 (2012).
10. Mercer, T. R., Dinger, M. E., Mattick, J. S. Long non-coding RNAs: insights into functions. Nat Rev Genet 10, 155-159 (2009).
11. Geisler, S., Coller, J. RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol 14, 699-712 (2013).
12. Wang, F. et al. Oncofetal Long Noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2. Hepatol 60, 1278-1290 (2014)
13. Stelzer, Y., Sagi, I., Yanuka, O., Eiges, R., Benvenisty, N. The noncoding RNA IPW regulates the imprinted DLK1-DIO3 locus in an induced pluripotent stem cell model of Prader-Willi syndrome. Nat Genet 46, 551-557 (2014).
14. Yuan, J. H. et al. A Long Noncoding RNA Activated by TGF-beta Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinoma. Cancer Cell 25, 666-681 (2014).
15. Gutschner, T., Diederichs, S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 9, 703-719 (2012).
16. Rinn, J. L., Chang, H. Y. Genome regulation by long noncoding RNAs. Annu Rev Biochem 81, 145-166 (2012).
17. Ji, P. et al. MALAT-1, a novel noncoding RNA, thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22, 8031-8041 (2003).
18. Shahrouki, P., Larsson, E. The non-coding oncogene: a case of missing DNA evidence? Front Genet 3, 170 (2012).
19. Tee, A. E. et al. The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1. Oncotarget 5, 1793-1804 (2014).
20. Zhou, Y., Zhang, X., Klibanski, A. MEG3 noncoding RNA: a tumor suppressor. J Mol Endocrinol 48, R45-R53 (2012).
21. Schmidt, L. H. et al. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J Thorac Oncol 6, 1984-1992 (2011).
22. Wu, W. et al. Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterol 144, 956-966 (2013).
23. Braconi, C. et al. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 30, 4750-4756 (2011).
24. Li, J. et al. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas. Int J Oncol 48, 723-733 (2016).
25. Wang, Y. et al. CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling. Cancer Lett 367, 122-128 (2015).
26. Yang, F. et al. Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol Cell 49, 1083-1096 (2013).
27. Sun, M. et al. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Mol Cancer 13, 68 (2014).
28. Gutschner, T. et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 73, 1180-1189 (2013).
29. Shi, X. et al. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer. Mol Carcinog 54 Suppl 1, E1-E12 (2015).
30. Thiery, J. P., Acloque, H., Huang, R. Y., Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890 (2009).
31. Baum, B., Settleman, J., Quinlan, M. P. Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol 19, 294-308 (2008).
32. Gupta, R. A. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076 (2010).
33. Kotake, Y. et al. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 30, 1956-1962 (2011).
34. Sultmann, H., Diederichs, S. Long Noncoding RNA: "LNCs" to Cancer. Eur Urol 65, 1152-1153 (2014).
35. Fan, Y. et al. TGF-beta-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin Cancer Res 20, 1531-1541 (2014).
36. Lin, Y., Dong, C., Zhou, B. P. Epigenetic regulation of EMT: the Snail story. Curr Pharm Des 20, 1698-1705 (2014).
37. Wang, Y., Shi, J., Chai, K., Ying, X., Zhou, B. P. The Role of Snail in EMT and Tumorigenesis. Curr Cancer Drug Targets 13, 963-972 (2013).
38. Yang, J., Weinberg, R. A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14, 818-829 (2008).
39. Brabletz, T., EMT and M. E. T. in metastasis: where are the cancer stem cells? Cancer Cell 22, 699-701 (2012).
40. Thomson, S. et al. Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. Cancer Res 65, 9455-9462 (2005).
41. Modali, S. D., Parekh, V. I., Kebebew, E., Agarwal, S. K. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors. Mol Endocrinol (Baltimore, Md.) 29, 224-237 (2015).
42. Li, Y. et al. Genome-wide DNA methylome analysis reveals epigenetically dysregulated non-coding RNAs in human breast cancer. Sci Rep 5, 8790 (2015).
43. Yan-Fang, T. et al. Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells. PloS one 10, e0126566 (2015).
44. Huang, J. et al. The anti-erbB3 antibody MM-121/SAR256212 in combination with trastuzumab exerts potent antitumor activity against trastuzumab-resistant breast cancer cells. Mol Cancer 12, 134 (2013).
45. Lyu, H. et al. The erbB3-and IGF-1 receptor-initiated signaling pathways exhibit distinct effects on lapatinib sensitivity against trastuzumab-resistant breast cancer cells. Oncotarget 7, 2921-2935 (2016).
46. Wang, S. et al. Functional cooperation of miR-125a, miR-125b, miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells. Cell Death Dis 4, e556 (2013).